118 related articles for article (PubMed ID: 38826257)
1. Disparities in access to Dolutegravir in West African children, adolescents and young adults aged 0-24 years living with HIV. A IeDEA Pediatric West African cohort analysis.
Desmonde S; Dame J; Malateste K; David A; Amorissani-Folquet M; N'Gbeche S; Sylla M; Takassi E; Kouakou K; Tossa LB; Yonaba C; Leroy V;
medRxiv; 2024 Jun; ():. PubMed ID: 38826257
[TBL] [Abstract][Full Text] [Related]
2. Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS.
Renner LA; Dicko F; Kouéta F; Malateste K; Gueye RD; Aka E; Eboua TK; Azondékon A; Okomo U; Touré P; Ekouévi D; Leroy V;
J Int AIDS Soc; 2013 Sep; 16(1):18024. PubMed ID: 24047928
[TBL] [Abstract][Full Text] [Related]
3. Effects of the COVID-19 Pandemic on ART Initiation and Access to HIV Viral Load Monitoring in Adults Living With HIV in West Africa: A Regression Discontinuity Analysis.
Ben Farhat J; Tiendrebeogo T; Malateste K; Poda A; Minga A; Messou E; Chenal H; Ezechi O; Ofotokun I; Ekouevi DK; Bonnet F; Barger D; Jaquet A;
J Acquir Immune Defic Syndr; 2024 Jun; 96(2):114-120. PubMed ID: 38427928
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort.
Amani-Bosse C; Dahourou DL; Malateste K; Amorissani-Folquet M; Coulibaly M; Dattez S; Emieme A; Barry M; Rouzioux C; N'gbeche S; Yonaba C; Timité-Konan M; Mea V; Ouédraogo S; Blanche S; Meda N; Seguin-Devaux C; Leroy V
J Int AIDS Soc; 2017 Apr; 20(1):21362. PubMed ID: 28453240
[TBL] [Abstract][Full Text] [Related]
6. Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study.
Dorward J; Sookrajh Y; Khubone T; van der Molen J; Govender R; Phakathi S; Lewis L; Bottomley C; Maraj M; Lessells RJ; Naidoo K; Butler CC; Van Heerden R; Garrett N
Lancet HIV; 2023 May; 10(5):e284-e294. PubMed ID: 37001536
[TBL] [Abstract][Full Text] [Related]
7. Virologic non-suppression and early loss to follow up among pregnant and non-pregnant adolescents aged 15-19 years initiating antiretroviral therapy in South Africa: a retrospective cohort study.
Nyakato P; Schomaker M; Fatti G; Tanser F; Euvrard J; Sipambo N; Fox MP; Haas AD; Yiannoutsos CT; Davies MA; Cornell M
J Int AIDS Soc; 2022 Jan; 25(1):e25870. PubMed ID: 35032096
[TBL] [Abstract][Full Text] [Related]
8. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
[TBL] [Abstract][Full Text] [Related]
9. 24-Month Clinical, Immuno-Virological Outcomes, and HIV Status Disclosure in Adolescents Living With Perinatally-Acquired HIV in the IeDEA-COHADO Cohort in Togo and Côte d'Ivoire, 2015-2017.
Dassi Tchoupa Revegue MH; Takassi UE; Tanoh Eboua F; Desmonde S; Amoussou-Bouah UB; Bakai TA; Jesson J; Dahourou DL; Malateste K; Aka-Dago-Akribi H; Raynaud JP; Arrivé E; Leroy V
Front Pediatr; 2021; 9():582883. PubMed ID: 34277512
[No Abstract] [Full Text] [Related]
10. ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing.
Moore CL; Turkova A; Mujuru H; Kekitiinwa A; Lugemwa A; Kityo CM; Barlow-Mosha LN; Cressey TR; Violari A; Variava E; Cotton MF; Archary M; Compagnucci A; Puthanakit T; Behuhuma O; Saϊdi Y; Hakim J; Amuge P; Atwine L; Musiime V; Burger DM; Shakeshaft C; Giaquinto C; Rojo P; Gibb DM; Ford D;
BMC Infect Dis; 2021 Jan; 21(1):5. PubMed ID: 33446115
[TBL] [Abstract][Full Text] [Related]
11. 12-month mortality and loss-to-program in antiretroviral-treated children: The IeDEA pediatric West African Database to evaluate AIDS (pWADA), 2000-2008.
Ekouevi DK; Azondekon A; Dicko F; Malateste K; Touré P; Eboua FT; Kouadio K; Renner L; Peterson K; Dabis F; Sy HS; Leroy V;
BMC Public Health; 2011 Jun; 11():519. PubMed ID: 21718505
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral treatment response of HIV-infected children after prevention of mother-to-child transmission in West Africa.
Ndondoki C; Dicko F; Ahuatchi Coffie P; Kassi Eboua T; Ekouevi DK; Kouadio K; Edmond Aka A; Malateste K; Dabis F; Amani-Bosse C; Toure P; Leroy V;
J Int AIDS Soc; 2014; 17(1):18737. PubMed ID: 24894377
[TBL] [Abstract][Full Text] [Related]
13. HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa.
Teasdale CA; Sogaula N; Yuengling KA; Wang C; Mutiti A; Arpadi S; Nxele M; Pepeta L; Mogashoa M; Rivadeneira ED; Abrams EJ
J Int AIDS Soc; 2018 Aug; 21(8):e25168. PubMed ID: 30094952
[TBL] [Abstract][Full Text] [Related]
14. Adolescent pregnancy at antiretroviral therapy (ART) initiation: a critical barrier to retention on ART.
Nuwagaba-Biribonwoha H; Kiragga AN; Yiannoutsos CT; Musick BS; Wools-Kaloustian KK; Ayaya S; Wolf H; Lugina E; Ssali J; Abrams EJ; Elul B;
J Int AIDS Soc; 2018 Sep; 21(9):e25178. PubMed ID: 30225908
[TBL] [Abstract][Full Text] [Related]
15. Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.
Dahourou DL; Amorissani-Folquet M; Malateste K; Amani-Bosse C; Coulibaly M; Seguin-Devaux C; Toni T; Ouédraogo R; Blanche S; Yonaba C; Eboua F; Lepage P; Avit D; Ouédraogo S; Van de Perre P; N'Gbeche S; Kalmogho A; Salamon R; Meda N; Timité-Konan M; Leroy V;
BMC Med; 2017 Apr; 15(1):85. PubMed ID: 28434406
[TBL] [Abstract][Full Text] [Related]
16. Excess mortality associated with mental illness in people living with HIV in Cape Town, South Africa: a cohort study using linked electronic health records.
Haas AD; Ruffieux Y; van den Heuvel LL; Lund C; Boulle A; Euvrard J; Orrell C; Prozesky HW; Tiffin N; Lovero KL; Tlali M; Davies MA; Wainberg ML;
Lancet Glob Health; 2020 Oct; 8(10):e1326-e1334. PubMed ID: 32971055
[TBL] [Abstract][Full Text] [Related]
17. Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics.
Fokam J; Nka AD; Mamgue Dzukam FY; Efakika Gabisa J; Bouba Y; Tommo Tchouaket MC; Ka'e AC; Ngoufack Jagni Semengue E; Takou D; Moudourou S; Fainguem N; Pabo W; Nayang Mundo RA; Kengni Ngueko AM; Ambe Chenwi C; Flore Yimga J; Nnomo Zam MK; Simo Kamgaing R; Tangimpundu C; Kamgaing N; Njom-Nlend AE; Ndombo Koki P; Kesseng D; Ndiang Tetang S; Kembou E; Ebiama Lifanda L; Pamen B; Ketchaji A; Saounde Temgoua E; Billong SC; Zoung-Kanyi Bissek AC; Hadja H; Halle EG; Colizzi V; Perno CF; Sosso SM; Ndjolo A
Medicine (Baltimore); 2023 May; 102(20):e33737. PubMed ID: 37335723
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study.
Ekouevi DK; Balestre E; Coffie PA; Minta D; Messou E; Sawadogo A; Minga A; Sow PS; Bissagnene E; Eholie SP; Gottlieb GS; Dabis F; ; Zannou DM; Ahouada C; Akakpo J; Ahomadegbé C; Bashi J; Gougounon-Houéto A; Azon-Kouanou A; Houngbé F; Koumakpaï S; Alihonou F; d'Almeida M; Hodonou I; Hounhoui G; Sagbo G; Tossa-Bagnan L; Adjide H; Drabo J; Bognounou R; Dienderé A; Traore E; Zoungrana L; Zerbo B; Sawadogo AB; Zoungrana J; Héma A; Soré I; Bado G; Tapsoba A; Yé D; Kouéta F; Ouedraogo S; Ouédraogo R; Hiembo W; Gansonré M; Messou E; Gnokoro JC; Koné M; Kouakou GM; Bosse CA; Brou K; Assi AI; Chenal H; Hawerlander D; Soppi F; Minga A; Abo Y; Bomisso G; Eholié SP; Amego MD; Andavi V; Diallo Z; Ello F; Tanon AK; Koule SO; Anzan KC; Guehi C; Aka EA; Issouf KL; Kouakou JC; N'gbeche MS; Touré P; Avit-Edi D; Kouakou K; Moh M; Yao VA; Folquet MA; Dainguy ME; Kouakou C; Méa-Assande VT; Oka-Berete G; Zobo N; Acquah P; Kokora MB; Eboua TF; Timité-Konan M; Ahoussou LD; Assouan JK; Sami MF; Kouadio C; Renner L; Goka B; Welbeck J; Sackey A; Owiafe SN; Wejse C; Silva ZJ; Paulo J; Rodrigues A; da Silva D; Medina C; Oliviera-Souto I; Ostergaard L; Laursen A; Sodemann M; Aaby P; Fomsgaard A; Erikstrup C; Eugen-Olsen J; Maïga MY; Diakité FF; Kalle A; Katile D; Traore HA; Minta D; Cissé T; Dembelé M; Doumbia M; Fomba M; Kaya AS; Traoré AM; Traoré H; Toure AA; Dicko F; Sylla M; Berthé A; Traoré HC; Koïta A; Koné N; N'diaye C; Coulibaly ST; Traoré M; Traoré N; Charurat M; Ajayi S; Dapiap S; Otu ; Igbinoba F; Benson O; Adebamowo C; James J; Obaseki ; Osakede P; Olasode J; Sow PS; Diop B; Manga NM; Tine JM; Signate Sy H; Ba A; Diagne A; Dior H; Faye M; Gueye RD; Mbaye AD; Patassi A; Kotosso A; Kariyare BG; Gbadamassi G; Komi A; Mensah-Zukong KE; Pakpame P; Lawson-Evi AK; Atakouma Y; Takassi E; Djeha A; Ephoévi-Gah A; Djibril Sel-H; Dabis F; Bissagnene E; Arrivé E; Coffie P; Ekouevi D; Jaquet A; Leroy V; Lewden C; Sasco A; Azani JC; Allou G; Balestre E; Bohossou F; Karcher S; Gonsan JM; Carrou JL; Lenaud S; Nchot C; Malateste K; Yao AR; Siloué B; Clouet G; Djetouan H; Doring A; Kouakou A; Rabourdin E; Rivenc J; Anglaret X; Ba B; Essanin JB; Ciaranello A; Datté S; Desmonde S; Diby JS; Gottlieb GS; Horo AG; Kangah SN; Malvy D; Meless D; Mounkaila-Harouna A; Ndondoki C; Shiboski C; Thiébaut R; Pac-Ci ; Abidjan
PLoS One; 2013; 8(6):e66135. PubMed ID: 23824279
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes with second-line dolutegravir in people with virological failure on first-line non-nucleoside reverse transcriptase inhibitor-based regimens in South Africa: a retrospective cohort study.
Asare K; Sookrajh Y; van der Molen J; Khubone T; Lewis L; Lessells RJ; Naidoo K; Sosibo P; van Heerden R; Garrett N; Dorward J
Lancet Glob Health; 2024 Feb; 12(2):e282-e291. PubMed ID: 38142692
[TBL] [Abstract][Full Text] [Related]
20. Barriers to viral load suppression among adolescents living with HIV on anti-retroviral therapy: a retrospective study in Tanga, Tanzania.
Mushy SE; Mtisi E; Mkawe S; Mboggo E; Ndega J; Yahya-Malima KI; Kamugunya D; Kilimba ES; Mlay BS; Muya A; Ngalesoni F
AIDS Res Ther; 2024 May; 21(1):35. PubMed ID: 38778318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
